Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Zoetis (NY:ZTS)

82.11 -7.09 (-7.95%)
Official Closing Price Updated: 4:10 PM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
News headline image
Zoetis (ZTS) Q3 2026 Earnings Call Transcript ↗
Competitive pressure eased in dermatology, but clinic visits softened 
Via The Motley Fool
Topics Earnings
News headline image
Zoetis (NYSE:ZTS) posts better-than-expected sales in Q3 2026
Animal health company Zoetis (NYSE:ZTS) reported revenue ahead of Wall Street’s expectations in Q3 2026, but revenue fell by 1.3% year on year to $2.39 billi... 
Via StockStory
News headline image
Zoetis Announces Third Quarter 2026 Results; Highlights Progress Advancing Innovation Across Diversified Portfolio and Narrows Full Year 2026 Revenue Guidance, Raises Full Year 2026 Adjusted EPS Guidance
From Zoetis Inc.
Via Business Wire
Zoetis (NYSE:ZTS) Dividend Quality Backed by Strong Profitability and Health Ratings ↗
Via Chartmill
Zoetis (NYSE:ZTS): A Quality Investing Case Study in Animal Health ↗
Via Chartmill
Zoetis (NYSE:ZTS): A Quality Dividend Stock for Income Investors With Room to Grow ↗
Via Chartmill
Zoetis (NYSE:ZTS) Looks Like a Decent Value Stock ↗
Via Chartmill
Zoetis (NYSE:ZTS): A Quality Dividend Stock for Dividend Investors ↗
Via Chartmill
News headline image
Earnings to watch: Zoetis (ZTS) reports Q3 results tomorrow
Animal health company Zoetis (NYSE:ZTS) will be reporting earnings this Thursday before market hours. Here’s what to look for. Zoetis missed analysts’ revenu... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 healthcare stock with impressive fundamentals and 2 we ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as... 
Via StockStory
Topics Economy
News headline image
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now ↗
The stocks listed here yield up to 5.8%. 
Via The Motley Fool
Topics Bonds
News headline image
Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment
From Zoetis Inc.
Via Business Wire
Zoetis (NYSE:ZTS) Offers Value and Quality in One Attractive Package ↗
Via Chartmill
News headline image
3 Reasons ZTS is Risky and 1 Stock to Buy Instead
Zoetis has gotten torched over the last six months - since April 2026, its stock price has dropped 37.6% to $75.34 per share. This was partly due to its soft... 
Via StockStory
News headline image
Zoetis Appoints Iris Knobloch to its Board of Directors
From Zoetis Inc.
Via Business Wire
News headline image
Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right Now ↗
Whether you want a higher 3% dividend yield or a quickly growing dividend that yields 1.2%, these two stocks look like rare opportunities. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Zoetis Declares Fourth Quarter 2026 Dividend
From Zoetis Inc.
Via Business Wire
News headline image
New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results
From Zoetis Inc.
Via Business Wire
News headline image
1 Mid-Cap Stock with Exciting Potential and 2 We Turn Down
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
Via StockStory
News headline image
Zoetis Stands by Guidance as Pet-Care Weakness and Competition Pressure Sales ↗
Zoetis (NYSE:ZTS) executives said the company remains confident in its previously issued guidance despite pressure in the U.S. companion-animal market, citing a weaker pet-care environment and... 
Via MarketBeat
News headline image
1 Oversold Stock Ready to Bounce Back and 2 Facing Challenges
Rock-bottom prices don’t always mean rock-bottom businesses. The stocks we’re examining today have all touched their 52-week lows, creating a classic investo... 
Via StockStory
News headline image
Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
From Zoetis Inc.
Via Business Wire
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
3 of Wall Street’s Favorite Stocks We’re Skeptical Of
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
News headline image
3 High-Yielding Dividend Stocks That Have Doubled Their Payouts in 5 Years ↗
These stocks have been generous with their dividend increases, and more may be on the way. 
Via The Motley Fool
News headline image
Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis (ZTS) Q2 2026 Earnings Call Transcript ↗
U.S. companion animal demand weakened, but livestock and diagnostics surged. 
Via The Motley Fool
Topics Earnings
News headline image
The Top 5 Analyst Questions From Zoetis’s Q2 Earnings Call
Zoetis delivered flat revenue in Q2, missing Wall Street expectations, while its adjusted earnings per share slightly exceeded consensus. The market’s positi... 
Via StockStory
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.